Medtronic's bid for US-based medical device company reviewed in Australia
MLex Summary: The proposed acquisition by Medtronic, via its indirect wholly owned subsidiary Project Saint Merger Sub, of US-based Scientia Vascular, will be reviewed by Australia’s antitrust watchdog. In a statement...To view the full article, register now.
Already a subscriber? Click here to view full article